DR. PUSHPAK CHIRMADE is a super specialist in the field of ADULT AND PEDIATRIC ONCOLOGY.
He has completed his D.M in ONCOLOGY & HEMATO-ONCOLOGY from Asia's eminent BJ Medical College & Ahmedabad Civil hospital, Gujarat Cancer Research Institute in year 2018. He is a GOLD MEDALIST in his M.D in Internal Medicine finals. He has done his MBBS from prestigious LTMMC and LTMGH, Sion hospital, Mumbai.
He is an expert in management of all types of hematological and oncological disorders. And is a specialist in chemotherapy, targeted therapy, hormonal therapy and immunotherapy.
He has also received the title of ESMO Certified Medical Oncologist (ECMO) given by European Society of Medical Oncology.
Dr. Pushpak Chirmade has experience in treating patients of Oncology (Cancerous lesion in any part of human body), Hematology (Blood diseases and blood cancers) and Bone Marrow Transplantation (BMT). He has sound theoretical familiarity with Radiation Oncology and Surgical Oncology.He is working as consultant at MGM Vashi, New Mumbai. and attached to D Y Patil Hospital and Terna Speciality Hospital & Research Centre.
Dr. Pushpak Chirmade has inimitable proficiency in managing diverse cancers like Head and neck cancer, Lung cancers, Esophageal cancer, Gastrointestinal cancers (cancers of stomach, intestine/colon, anal canal, liver, gall bladder and pancreas).Genitourinary cancers (cancers of kidney, urinary bladder, germ cell tumors, prostate). Sarcomas (bone and soft tissue cancers) and Skin cancers.
He is also an expert in treating cancers occurring in females like Breast Cancer, Cervical Cancer, Ovarian Cancer and Uterine Cancer.
He has enthusiastic concern for the management of Blood Cancers and Blood Disorders like Leukemia, Lymphoma, Multiple Myeloma, Anemia, Thrombocytopenia, Bone Marrow failure etc.
He has published numerous articles in the national and international journals and has also presented oral papers and posters at various conferences.
He is a member of European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO).
AWARDS AND RECOGNITION